Elanco
VC Fund
Greenfield, United States
Elanco is a global animal health company that benefits people as well as animals through their vision: food and companionship enriching life.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Elanco invests in
Stages Elanco invests in
Countries Elanco invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aaron Schacht
|
|||
Dave Kinard
|
|||
Dirk Ehle
|
|||
Jeffrey N. Simmons
|
|||
Jonathan Stone
|
Investment Focus
Industry
- Therapeutics 2 (40%)
- Biotechnology 2 (40%)
- AgTech 1 (20%)
- Farming 1 (20%)
- Livestock 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
- Corporate Round 1 (20%)
Country
- United States 3 (60%)
- Switzerland 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Aaron Schacht
Executive Vice President
|
Executive Vice President | Total investments: 0 | Find email | |
|
Dave Kinard
Executive Vice President Human Resources, Corporate Affairs & Administration
|
Executive Vice President Human Resources, Corporate Affairs & Administration | Total investments: 0 | Find email | |
|
Dirk Ehle
EVP & President Elanco Animal Health Europe
|
EVP & President Elanco Animal Health Europe | Total investments: 0 | Find email | |
|
Jeffrey N. Simmons
Founder & President and CEO
|
Founder & President and CEO | Total investments: 0 | Find email | |
|
Jonathan Stone
Senior Director, SolutionOps Engineering
|
Senior Director, SolutionOps Engineering | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Athian
|
Athian enables animal agriculture producers to monetize their sustainability efforts — whether it's past work or progress towards a future sustainability goal. | $4M / Series A / Nov 19, 2025 | |
|
Athian
|
Athian enables animal agriculture producers to monetize their sustainability efforts — whether it's past work or progress towards a future sustainability goal. | $5M / Seed / May 01, 2023 | |
Stonehaven Incubate
|
Stonehaven Incubate looks at disruptive technologies in human health and identifies the unique opportunities for animals. | Corporate Round / Apr 06, 2021 | |
Resilient Biotics
|
Resilient Biotics, Inc. is utilizing big data analytics to design microbiome-based therapeutics and advanced screening methods for prevention and treatment of deadly infectious diseases, with an initial focus combating respiratory disease in livestock animals. Resilient’s goal is to provide more effective treatment strategies while reducing thelivestock animal industry’s current dependency on antibiotics. | $7.2M / Series A / Jan 29, 2021 | |
Boragen
|
Boragen develops synthetic chemistry platforms designed to produce next-generation fungicides. The platform supports sustainable farming methods by creating a compound that decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy. The company utilizes boron’s uniqueproperties to design and develop novel solutions targeting needs in crop protection, animal health, and human health.Founded in 2015, Boragen is based in Durham, North Carolina. | $10M / Series A / Mar 02, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Elanco invest in?
Elanco invests primarily in Therapeutics, Biotechnology and AgTech startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Elanco?
Public channels for Elanco include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Elanco?
The team at Elanco includes Aaron Schacht (Executive Vice President), Dave Kinard (Executive Vice President Human Resources, Corporate Affairs & Administration) and Dirk Ehle (EVP & President Elanco Animal Health Europe), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
